Literature DB >> 19999359

Vocal exercise versus voice rest following botulinum toxin injections: a randomized crossover trial.

Randal C Paniello1, Julia D Edgar, Joel S Perlmutter.   

Abstract

OBJECTIVES: The intensity of muscle activity immediately following intramuscular botulinum toxin injection may affect the clinical efficacy of the injection. We tested this effect in patients who underwent botulinum toxin injections for adductor spasmodic dysphonia.
METHODS: Patients were studied over 3 to 5 injection cycles. Cycle 1 was the baseline control; cycle 2 was randomized between a 1-hour reading aloud task ("exercise") and a 24-hour period of complete voice rest. For cycle 3, the patient completed the task not performed in cycle 2. Patients who were willing to continue for cycles 4 and 5 repeated the experiment at one half the injection dosage. Efficacy was determined with a battery of voice recordings and clinical outcomes instruments administered via telephone at 2- to 4-week intervals. The primary outcome measure was the result of the Voice-Related Quality of Life (VRQOL) instrument.
RESULTS: Nine patients (8 women, 1 man) with a mean age of 60.8 years (range, 42 to 76 years) completed at least 3 injection cycles. The VRQOL results were significantly higher for cycles that followed the exercise task. The patients reported subjectively that these were some of the best injection cycles they had ever experienced. Some achieved equivalent results with the half-dose injection plus exercise. The VRQOL results after voice rest cycles were not significantly different from the patients' baseline cycles.
CONCLUSIONS: These results support the conclusion that a period of intense vocalization immediately following laryngeal botulinum toxin injections improves the efficacy of the injection. Possible mechanisms are proposed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19999359      PMCID: PMC3065292     

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  20 in total

1.  Effect of volume and concentration on the diffusion of botulinum exotoxin A.

Authors:  T S Jeffrey Hsu; Jeffrey S Dover; Kenneth A Arndt
Journal:  Arch Dermatol       Date:  2004-11

2.  Perceptual analyses of spasmodic dysphonia before and after treatment.

Authors:  Michael P Cannito; Gayle E Woodson; Thomas Murry; Brenda Bender
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-12

3.  Effect of muscle activity immediately after botulinum toxin injection for writer's cramp.

Authors:  R Chen; B I Karp; S R Goldstein; W Bara-Jimenez; Z Yaseen; M Hallett
Journal:  Mov Disord       Date:  1999-03       Impact factor: 10.338

4.  Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction.

Authors:  L L Simpson
Journal:  J Pharmacol Exp Ther       Date:  1980-01       Impact factor: 4.030

5.  Voice handicap index results for older patients with adductor spasmodic dysphonia.

Authors:  Judith M Wingate; Bari Hoffman Ruddy; Donna S Lundy; Jeffrey Lehman; Roy Casiano; Savita P Collins; Gayle E Woodson; Christine Sapienza
Journal:  J Voice       Date:  2005-03       Impact factor: 2.009

6.  Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.

Authors:  N D Hogikyan; W P Wodchis; C Spak; P R Kileny
Journal:  J Voice       Date:  2001-12       Impact factor: 2.009

7.  Acoustic variations in reading produced by speakers with spasmodic dysphonia pre-botox injection and within early stages of post-botox injection.

Authors:  Christine M Sapienza; Michael P Cannito; Thomas Murry; Ryan Branski; Gayle Woodson
Journal:  J Speech Lang Hear Res       Date:  2002-10       Impact factor: 2.297

8.  The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans.

Authors:  R Eleopra; V Tugnoli; D De Grandis
Journal:  Mov Disord       Date:  1997-01       Impact factor: 10.338

9.  Short-term electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients.

Authors:  S Hesse; M T Jahnke; D Luecke; K H Mauritz
Journal:  Neurosci Lett       Date:  1995-12-01       Impact factor: 3.046

10.  Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.

Authors:  A Blitzer; M F Brin; C F Stewart
Journal:  Laryngoscope       Date:  1998-10       Impact factor: 3.325

View more
  1 in total

Review 1.  Speech-Language Pathology Evaluation and Management of Hyperkinetic Disorders Affecting Speech and Swallowing Function.

Authors:  Julie M Barkmeier-Kraemer; Heather M Clark
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-09-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.